The impact of “4 + 7” volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis
Abstract Background In 2019, Chinese government launched a nationwide volume-based drug procurement aiming at reducing drug prices and saving drug costs through economies of scale, which aroused widespread attention. The first round of the policy pilot was implemented in 4 municipalities and 7 sub-p...
Guardado en:
Autores principales: | Ying Yang, Ruiwen Tong, Shicheng Yin, Lining Mao, Luxinyi Xu, Siyu Hao, Zongfu Mao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c35a4f2eaefa4e73b2980ad46aa3d79a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of Innovations in Procurement Practices
por: Tatyana Vladimirovna Kasyanova
Publicado: (2018) -
Understanding the Determinants and Specifics of Pre-Commercial Procurement
por: Delina,Radoslav, et al.
Publicado: (2021) -
CERIMETRIC DETERMINATION OF FOUR ANTIHYPERTENSIVE DRUGS IN PHARMACEUTICAL PREPARATIONS
por: EL-DIDAMONY,A.M, et al.
Publicado: (2011) -
Comparative analysis of classifications of public procurement
por: Yuriy Hruzky
Publicado: (2021) -
Public procurement in Ukraine: analysis of advantages and disadvantages
por: O.A., et al.
Publicado: (2021)